Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne J B van Stipdonk

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|June 27, 2008
Development of CTL memory despite arrested clonal expansionMarianne J B van Stipdonk, Marjolein Sluijter, Wanda G H Han, et al.
Cancer Research|October 1, 2009
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100Marianne J B van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, et al.
Nature Immunology|March 18, 2003
Dynamic programming of CD8+ T lymphocyte responsesMarianne J B van Stipdonk, Gijs Hardenberg, Martijn S Bijker, et al.
Immunity|March 26, 2002
CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cellsDirk Homann, Angelika Jahreis, Tom Wolfe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|June 27, 2008
Development of CTL memory despite arrested clonal expansionMarianne J B van Stipdonk, Marjolein Sluijter, Wanda G H Han, et al.
Cancer Research|October 1, 2009
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100Marianne J B van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, et al.
Nature Immunology|March 18, 2003
Dynamic programming of CD8+ T lymphocyte responsesMarianne J B van Stipdonk, Gijs Hardenberg, Martijn S Bijker, et al.
Immunity|March 26, 2002
CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cellsDirk Homann, Angelika Jahreis, Tom Wolfe, et al.
Pageof 1